Dolby Laboratories, Inc. — Q1 FY2017 Form 10-Q
Reporting period: Fiscal quarter ended December 30, 2016. The prior-year comparison ended January 1, 2016 and covered 14 weeks, versus 13 weeks in the current quarter; this limits direct comparability. Financial amounts below are in millions unless stated otherwise.
Financial performance
| Metric | Q1 FY2017 | Prior-year quarter | Change |
|---|---|---|---|
| Revenue | $266.3 | $240.8 | +10.6% |
| Gross profit / gross margin | $236.3 / 88.7% | $211.0 / 87.6% | Margin +1.1 percentage points |
| Operating income / margin | $66.1 / 24.8% | $39.2 / 16.3% | Operating income +68.6% |
| Net income attributable to Dolby | $53.4 | $30.9 | +72.7% |
| Diluted EPS | $0.51 | $0.30 | +70.0% |
| Operating cash flow | $67.8 | $67.4 | +$0.4 |
| Capital expenditures | $22.6 | $24.4 | -$1.8 |
- Licensing revenue was $232.7 million (+10%); products revenue was $28.2 million (+14%); services revenue was $5.4 million (+10%). Licensing supplied 87% of total revenue.
- Operating expenses were $170.2 million, down 1% year over year: R&D rose 8% to $57.5 million, while sales and marketing fell 4% to $71.2 million and G&A fell 6% to $41.5 million.
- Effective tax rate was 20.8%, versus 21.5%. The company cited increased benefit from foreign earnings and settlement of a California state tax audit, partly offset by lower federal R&D credit benefits.
Balance sheet and liquidity
- At December 30, 2016, cash and cash equivalents were $512.8 million; short- and long-term investments totaled $515.2 million. Combined cash, cash equivalents, and investments were approximately $1.028 billion.
- Working capital was $603.8 million, compared with $546.6 million at September 30, 2016. Total assets were $2.331 billion and total liabilities were $330.0 million.
- The balance sheet presents no interest-bearing borrowings; interest expense was $26,000 for the quarter. Management said available liquidity and operating cash flows should meet anticipated cash needs for at least 12 months.
- Approximately $688 million, or 67%, of cash and investments was held by foreign subsidiaries; repatriation could incur U.S. federal and foreign withholding taxes, net of applicable credits.
- Financing cash outflows included $25.0 million of share repurchases and $14.2 million of dividends. The quarterly dividend was $0.14 per share.
Material changes and operating developments
- Licensing growth reflected higher automotive recoveries, Voice Licensing and Dolby Cinema revenue, increased gaming-console shipments, higher broadcast set-top-box volumes, and mobile patent licensing growth, including new customers. Recoveries from licensee settlements and back payments are recurring but fluctuate and are uncertain.
- Product gross margin increased to 37% from 23%, driven by improved product mix and lower excess-and-obsolete inventory charges, alongside higher cinema product sales. Services margin rose to 23% from 14%, largely due to higher production activity and fixed-cost utilization.
- Operating cash flow was nearly flat year over year. Investing cash outflow was $26.7 million versus $80.0 million, primarily because the prior-year quarter included a $105.0 million patent portfolio acquisition. Financing outflow declined to $39.0 million, mainly due to lower repurchases.
- Foreign currency translation and investment losses reduced other comprehensive income by $9.5 million, leaving accumulated other comprehensive loss of $19.7 million.
Outlook, risks, and unusual items
- The filing provides no quantified revenue, earnings, or cash-flow guidance. Management highlighted potential growth from Dolby Atmos, Dolby Vision, Dolby Cinema, and mobile licensing, while emphasizing that adoption, content availability, customer choices, and market conditions remain uncertain.
- Management reported 70 Dolby Cinema locations operational and projected 140 by the end of FY2017. It also described expanding Dolby Atmos device and content adoption and Dolby Vision availability through additional TV partners and streaming content; these are business targets and developments, not formal financial guidance.
- Key risks include dependence on licensees’ product shipments and royalty reporting; competing or optional industry standards; patent expirations and unauthorized use of IP; pricing pressure; secular declines in PCs and optical media; and execution, adoption, and content risks for newer initiatives. International operations bring currency, regulatory, tax, and IP-enforcement exposure.
- Legal proceedings arise in the ordinary course; the company did not expect them to materially affect results or financial condition, but stated outcomes are uncertain and potential losses could not be estimated in some cases. Contractual commitments totaled $289.6 million, including naming rights, leases, purchase obligations, and donation commitments.
- A preliminary goodwill impairment assessment after an internal reorganization found reporting-unit fair values significantly above carrying values; the assessment was not final, with completion expected in Q2 FY2017. On January 25, 2017, the board approved a $200 million increase to the repurchase authorization, leaving approximately $227 million available.
- Disclosure controls were assessed as effective; no material change in internal control over financial reporting was reported. The quarter also included adoption of a consolidation accounting standard with no financial-statement impact.
Important facts for investors to verify
- Adjust year-over-year comparisons for the prior period’s additional week, and assess whether licensing growth and higher earnings persist.
- Determine how much licensing revenue came from recoveries and whether those payments are repeatable.
- Track adoption and monetization of Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby Voice against the stated deployment and content milestones.
- Review the final goodwill assessment, foreign-held liquidity and potential repatriation taxes, and the size and timing of capital returns.
- Monitor royalty-reporting disputes, IP enforcement and patent expirations, competition and pricing pressure, and outstanding legal and contractual exposures.